In a regulatory 8-K filing, the company states: "On January 25, 2023, Carrie Anderson, CFO of Integra LifeSciences Holdings Corporation notified the Company of her decision to resign, effective as of February 2, 2023, to pursue another professional opportunity. The Company intends to commence a comprehensive search process to identify a new CFO. In the interim, Mathieu P. Aussermeier, Vice President, Corporate Finance, Investor Relations & Treasurer, and Jeffrey Mosebrook, Senior Vice President, Finance, will assume Ms. Anderson’s financial duties and responsibilities and report to Jan De Witte, the Company’s President and CEO. Mr. Aussermeier will be responsible for treasury, financial planning and analysis, and investor relations. Mr. Mosebrook will oversee accounting, tax, internal audit and global business services. During the interim period, Mr. Mosebrook will serve as the Company’s principal financial officer in addition to serving as principal accounting officer."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on IART:
- Campbell Soup names Carrie Anderson as new CFO
- Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials
- Integra LifeSciences reiterates plans to initiate $150M share buyback in 2023
- Integra sees FY22 adjusted EPS above $3.29-$3.33 range, consensus $3.30
- Integra LifeSciences sees Q4 revenue $397M-$398M, consensus $397.5M